Delrin 4D™

The Industry Challenge

Across the globe, billions of self‑administered injection devices are produced every year—an essential backbone of modern pharmaceutical treatment. Yet this success comes with a monumental cost: kilotons of plastic consumed annually, almost all of it destined for incineration after a single use.

As demand accelerates, so does the urgency. The industry faces a defining moment: reduce CO₂ impact, rethink end‑of‑life pathways, and streamline operations in a world where productivity, cost efficiency, and supply‑chain resilience are under unprecedented pressure.

Complicating matters further, today’s devices rely on multi‑material constructions that hinder circularity and amplify logistical complexity. The companies that overcome these barriers won’t just improve their products—they will reshape the competitive landscape of a multibillion‑unit market.

Introducing Delrin 4D™

Delrin 4D™ is a concept device with all plastic parts made entirely from Delrin®. Combining the superior performance attributes of Delrin® and the numerous benefits of a mono-material device approach, such as design and manufacturing simplification and enabling disassembly, reusability and circularity options. Delrin 4D™ can be incorporated into next-generation drug delivery devices to address sustainability challenges, while maximizing productivity, simplifying logistics, de-risking supply chains and ensuring regulatory compliance.

A future with lower CO₂ impact and higher efficiency isn’t theoretical. It starts here.